Tarik Möröy

10.9k total citations · 1 hit paper
166 papers, 8.7k citations indexed

About

Tarik Möröy is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Tarik Möröy has authored 166 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Molecular Biology, 59 papers in Immunology and 56 papers in Genetics. Recurrent topics in Tarik Möröy's work include Blood disorders and treatments (49 papers), RNA modifications and cancer (25 papers) and RNA Research and Splicing (21 papers). Tarik Möröy is often cited by papers focused on Blood disorders and treatments (49 papers), RNA modifications and cancer (25 papers) and RNA Research and Splicing (21 papers). Tarik Möröy collaborates with scholars based in Germany, Canada and United States. Tarik Möröy's co-authors include Holger Karsunky, Malte Bachmann, Christoph Geisen, Branko Zevnik, Christian Kosan, H. Lovec, Raif Yücel, Ludger Klein‐Hitpaß, Lothar Vaßen and Hans Georg Mannherz and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Tarik Möröy

162 papers receiving 8.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Features of systemic lupus erythematosus in Dnase1-deficient mice

2000 623 citations Tarik Möröy et al. profile →

Peers

Countries citing papers authored by Tarik Möröy

Since Specialization

Citations

This map shows the geographic impact of Tarik Möröy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tarik Möröy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tarik Möröy more than expected).

Fields of papers citing papers by Tarik Möröy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tarik Möröy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tarik Möröy. The network helps show where Tarik Möröy may publish in the future.

Co-authorship network of co-authors of Tarik Möröy

This figure shows the co-authorship network connecting the top 25 collaborators of Tarik Möröy. A scholar is included among the top collaborators of Tarik Möröy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tarik Möröy. Tarik Möröy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	GFI1B specifies developmental potential of innate lymphoid cell progenitors in the lungs 2024 ·Science Immunology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jaring Schreuder, (unknown), M. Zeeshan Chaudhry, Nicolas Jacquelot, Verena C. Wimmer, Cyril Seillet, Tarik Möröy, Gabrielle T. Belz	4
2	The RNA helicase DDX3 and its role in c-MYC driven germinal center-derived B-cell lymphoma 2023 ·Frontiers in Oncology ·(unknown), (unknown), Cyrus Khandanpour, Tarik Möröy	6
3	The X-Linked Helicase DDX3X Is Required for Lymphoid Differentiation and MYC-Driven Lymphomagenesis 2022 ·Cancer Research ·(unknown), (unknown), Jennifer Fraszczak, Julie Ross, Peiman Shooshtarizadeh, Riyan Chen, Tarik Möröy	8
4	Targeting the MYC interaction network in B-cell lymphoma via histone deacetylase 6 inhibition 2022 ·Oncogene ·(unknown), (unknown), (unknown), (unknown), Mandy Beyer, (unknown), (unknown), (unknown), (unknown), Simon Poepsel, Florian Heyd, Petra Beli, Tarik Möröy, Siavosh Mahboobi, Oliver H. Krämer, Christian Kosan	11
5	GFI1 tethers the NuRD complex to open and transcriptionally active chromatin in myeloid progenitors 2021 ·Communications Biology ·(unknown), Jennifer Fraszczak, Charles Joly-Beauparlant, Halil Bagci, Christian Trahan, (unknown), Peiman Shooshtarizadeh, Riyan Chen, (unknown), Jean‐François Côté, Marlene Oeffinger, Arnaud Droit, Tarik Möröy	7
6	Targeting MYC: From understanding its biology to drug discovery 2020 ·European Journal of Medicinal Chemistry ·Julie Ross, (unknown), Jessica Plescia, Patricia LaPlante, Kevin M. McBride, Nicolas Moitessier, Tarik Möröy	22
7	Deletion of the Miz-1 POZ Domain Increases Efficacy of Cytarabine Treatment in T- and B-ALL/Lymphoma Mouse Models 2019 ·Cancer Research ·Julie Ross, Marissa Rashkovan, Jennifer Fraszczak, Charles Joly-Beauparlant, Charles Vadnais, (unknown), Arnaud Droit, Christian Kosan, Tarik Möröy	18
8	Reduced expression but not deficiency of GFI1 causes a fatal myeloproliferative disease in mice 2018 ·Leukemia ·Jennifer Fraszczak, Charles Vadnais, Marissa Rashkovan, Julie Ross, (unknown), Riyan Chen, Damien Grapton, Cyrus Khandanpour, Tarik Möröy	15
9	Generation and characterization of human iPSC line MML-6838-Cl2 from mobilized peripheral blood derived megakaryoblasts 2016 ·Stem Cell Research ·Marten Hansen, Eszter Varga, (unknown), Nelleke P.M. Brouwer, (unknown), Clemens Mellink, Anne-Marie Van Der Kevie-Kersemaekers, Tarik Möröy, Bert van der Reijden, Marieke von Lindern, Emile van den Akker	11
10	Loss of heterogeneous nuclear ribonucleoprotein L (HNRNP L) leads to mitochondrial dysfunction, DNA damage response and caspase-dependent cell death in hematopoietic stem cells 2016 ·Experimental Hematology ·(unknown), Marie‐Claude Gaudreau, Damien Grapton, Charles Vadnais, Jennifer Fraszczak, Brian T. Wilhelm, François Robert, Florian Heyd, Tarik Möröy	1
11	Growth Factor Independence 1 Antagonizes a p53-Induced DNA Damage Response Pathway in Lymphoblastic Leukemia 2013 ·Cancer Cell ·Cyrus Khandanpour, James D. Phelan, Lothar Vaßen, Judith Schütte, Riyan Chen, Shane R. Horman, Marie‐Claude Gaudreau, (unknown), Jinfang Zhu, William E. Paul, Ulrich Dührsen, Berthold Göttgens, H. Leighton Grimes, Tarik Möröy	57
12	Gfi1 as a regulator of p53 and a therapeutic target for ALL 2013 ·Oncotarget ·Cyrus Khandanpour, Tarik Möröy	8
13	GFI1 and GFI1B control the loss of endothelial identity of hemogenic endothelium during hematopoietic commitment 2012 ·Blood ·Christophe Lancrin, Milena Mazan, Monika Stefańska, Rahima Patel, Monika Lichtinger, Guilherme Costa, Özge Vargel Bölükbaşı, Nicola K. Wilson, Tarik Möröy, Constanze Bonifer, Berthold Göttgens, Valérie Kouskoff, Georges Lacaud	125
14	Evidence that Growth factor independence 1b regulates dormancy and peripheral blood mobilization of hematopoietic stem cells 2010 ·Blood ·Cyrus Khandanpour, Ehssan Sharif‐Askari, Lothar Vaßen, Marie‐Claude Gaudreau, Jinfang Zhu, William E. Paul, Taro Okayama, Christian Kosan, Tarik Möröy	61
15	Zinc Finger Protein Gfi1 Controls the Endotoxin-Mediated Toll-Like Receptor Inflammatory Response by Antagonizing NF-κB p65 2010 ·Molecular and Cellular Biology ·Ehssan Sharif‐Askari, Lothar Vaßen, Christian Kosan, Cyrus Khandanpour, Marie‐Claude Gaudreau, Florian Heyd, Taro Okayama, Jianmin Jin, (unknown), H. Leighton Grimes, Hui Zeng, Tarik Möröy	26
16	Runx3 Regulates Integrin αE/CD103 and CD4 Expression during Development of CD4−/CD8+ T Cells 2005 ·The Journal of Immunology ·(unknown), Michaela Petter, Takeshi Egawa, Kirsten Laule-Kilian, (unknown), (unknown), Yvonne Ludwig, Hidehiro Fukuyama, Hedda Wardemann, (unknown), Tarik Möröy, Ichiro Taniuchi, Viktor Steimle, Dan R. Littman, Marc Ehlers	107
17	Runx3 regulates integrin αE/CD103 and CD4 expression during development of CD4−/CD8+ T cells 2005 ·The Journal of Immunology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Tarik Möröy, (unknown), (unknown), Dan R. Littman, Marc Ehlers	3
18	The new sulindac derivative IND 12 reverses Ras-induced cell transformation. 2002 ·Ghent University Academic Bibliography (Ghent University) ·(unknown), Peter Herter, Philip R. Debruyne, (unknown), (unknown), Ulrike Herbrand, (unknown), Karl‐Heinz Glüsenkamp, G Winde, Marc Mareel, Tarik Möröy, Oliver Müller	25
19	The DNA target site for the Brn-3 POU family transcription factors can confer responsiveness to cyclic AMP and removal of serum in neuronal cells 1994 ·Nucleic Acids Research ·Vishwanie Budhram‐Mahadeo, Thomas Theil, Peter J. Morris, Karen A. Lillycrop, Tarik Möröy, D.S. Latchman	37
20	Structure and expression of hcr, a locus rearranged with c-myc in a woodchuck hepatocellular carcinoma. 1989 ·PubMed ·Tarik Möröy, Jeanne Étiemble, Lydie Bougueleret, Michelle Hadchouel, Pierre Tiollais, Marie‐Annick Buendia	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact